Recent EHV-1 outbreaks have been alarming in their high neurological attack rate in both vaccinated and unvaccinated horses. Therapeutic intervention with antiviral nucleoside analogs may limit the spread of the virus during an active EHV-1 outbreak while protecting infected horses from the crippling effects of severe neurological disease.